E-LIB Suche - Ergebnisse für: Grosjean, Heidi A. I.

1

Impact of Performance Status on Survival Outcomes and Healt..:

Meyers, Daniel E. ; Pasternak, Meghann ; Dolter, Samantha...
JTO Clinical and Research Reports. 4 (2023) 4 - p. 100482 , 2023

Link: https://doi.org/10.1016/..

2

Outcomes of patients with solid tumour malignancies treated..:

Gan, Chun L. ; Stukalin, Igor ; Meyers, Daniel E....
European Journal of Cancer. 151 (2021) - p. 115-125 , 2021

Link: https://doi.org/10.1016/..

3

Effectiveness and Safety of First-Line Pembrolizumab in Old..:

Grosjean, Heidi A. I. ; Dolter, Samantha ; Meyers, Daniel E....
Current Oncology. 28 (2021) 5 - p. 4213-4222 , 2021

Link: https://doi.org/10.3390/..

4

Outcomes of patients with solid tumour malignancies treated..:

Gan, Chun L ; Stukalin, Igor ; Meyers, Daniel E...
Gan , C L , Stukalin , I , Meyers , D E , Dudani , S , Grosjean , H A I , Dolter , S , Ewanchuk , B W , Goutam , S , Sander , M , Wells , C , Pabani , A , Cheng , T , Monzon , J , Morris , D , Basappa , N S , Pal , S K , Wood , L A , Donskov , F , Choueiri , T K & Heng , D Y C 2021 , ' Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials ' , European Journal of Cancer , vol. 151 , pp. 115-125 . https://doi.org/10.1016/j.ejca.2021.04.004. , 2021

Link: https://pure.au.dk/porta..

5

Effectiveness and Safety of First-Line Pembrolizumab in Old..:

Heidi A. I. Grosjean ; Samantha Dolter ; Daniel E. Meyers...
Thoracic Oncology. , 2021

Link: https://doi.org/10.3390/..

6

Effectiveness and Safety of First-Line Pembrolizumab in Old..:

Heidi A. I. Grosjean ; Samantha Dolter ; Daniel E. Meyers...
https://www.mdpi.com/1718-7729/28/5/357. , 2021

Link: https://doi.org/10.3390/..

7

Impact of Performance Status on Survival Outcomes and Healt..:

Daniel E. Meyers, MD, MSc ; Meghann Pasternak, MD, MSc ; Samantha Dolter, MD...
http://www.sciencedirect.com/science/article/pii/S2666364323000218. , 2023

Link: https://doi.org/10.1016/..

8

Platelet-Mediated NET Release Amplifies Coagulopathy and Dr..:

Kim, Seok-Joo ; Carestia, Agostina ; McDonald, Braedon...
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

9

Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognos..:

Navani, Vishal ; Meyers, Daniel E. ; Ruan, Yibing...
Clinical Lung Cancer. 24 (2023) 3 - p. e152-e159 , 2023

Link: https://doi.org/10.1016/..

10

The linker region of breast cancer resistance protein ABCG2..:

Macalou, S. ; Robey, R. W. ; Jabor Gozzi, G....
Cellular and Molecular Life Sciences. 73 (2015) 9 - p. 1927-1937 , 2015

Link: https://doi.org/10.1007/..

11

Non‐surgical periodontal therapy with systemic antibiotics ..:

Keestra, J. A. J. ; Grosjean, I. ; Coucke, W...
Journal of Periodontal Research. 50 (2014) 6 - p. 689-706 , 2014

Link: https://doi.org/10.1111/..

12

Non‐surgical periodontal therapy with systemic antibiotics ..:

Keestra, J. A. J. ; Grosjean, I. ; Coucke, W...
Journal of Periodontal Research. 50 (2014) 3 - p. 294-314 , 2014

Link: https://doi.org/10.1111/..

13

Hepatitis A and B in persons with learning disabilities liv..:

Laurichesse, H. ; Henquell, C. ; Gourdon, F....
Infection. 26 (1998) 2 - p. 133-134 , 1998

Link: https://doi.org/10.1007/..

14

Soluble serum CD23 levels and CD23 molecule expression on i..:

Lachaux, A. ; Grosjean, I. ; Bonnefoy, J. Y..
European Journal of Pediatrics. 155 (1996) 10 - p. 918-918 , 1996

Link: https://doi.org/10.1007/..

15

L'« enfant-roi » : une pathologie moderne ? Réflexions soci..:

de Becker, E. ; Lescalier-Grosjean, I.
Archives de Pédiatrie. 12 (2005) 9 - p. 1411-1418 , 2005

Link: https://doi.org/10.1016/..